Glanbia plc (FRA:GL9)

Market Cap	3.58B
Revenue (ttm)	3.35B
Net Income (ttm)	102.54M
Shares Out	n/a
EPS (ttm)	0.39
PE Ratio	34.87
Forward PE	12.01
Dividend	0.41 (2.87%)
Ex-Dividend Date	Aug 21, 2025

Volume	n/a
Average Volume	29
Open	14.12
Previous Close	14.10
Day's Range	14.12 - 14.12
52-Week Range	8.90 - 15.50
Beta	n/a
RSI	49.34
Earnings Date	Feb 25, 2026

About Glanbia

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; pro...

• Industry: Pharmaceutical Preparations
• Founded: 1964
• Employees: 5,791
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GL9

Financial Performance

In 2024, Glanbia's revenue was $3.84 billion, a decrease of -29.23% compared to the previous year's $5.43 billion. Earnings were $164.70 million, a decrease of -52.18%.

Financial numbers in USD